​

Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?


OverviewRevenueFinancialsChart

Gyre Therapeutics Ownership Summary


Gyre Therapeutics is owned by 9.69% institutional investors, 74.40% insiders, and 15.91% retail investors. Sc china is the largest institutional shareholder, holding 3.73% of GYRE shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 0.98% of its assets in Gyre Therapeutics shares.

GYRE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGyre Therapeutics9.69%74.40%15.91%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sc china3.75M3.73%$27.49M
Vanguard capital management1.47M1.46%$10.75M
Vanguard group1.20M1.35%$8.48M
Blackrock funding, inc. /de1.18M1.17%$8.61M
Octagon capital advisors lp954.42K1.05%$6.29M
Geode capital management681.33K0.68%$5.00M
State street246.87K0.25%$1.81M
Vanguard fiduciary trust243.37K0.24%$1.78M
Ubs group203.88K0.20%$1.49M
Charles schwab investment management184.29K0.20%$1.21M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sc china3.75M2.17%$27.49M
Octagon capital advisors lp954.42K0.57%$6.29M
Sbi securities169.72K0.03%$1.24M
Strs ohio40.40K0.00%$296.13K
Activest wealth management533.000.00%$3.91K
Strategic financial concepts461.000.00%$3.38K
Vanguard fiduciary trust243.37K0.00%$1.78M
Tower research capital llc (trc)2.47K0.00%$16.27K
Geode capital management681.33K0.00%$5.00M
Ubs group203.88K0.00%$1.49M

Top Buyers

HolderShares% AssetsChange
Octagon capital advisors lp954.42K0.57%954.42K
Vanguard capital management1.47M0.00%589.78K
Ubs group203.88K0.00%185.12K
Blackrock funding, inc. /de1.18M0.00%181.12K
Geode capital management681.33K0.00%148.38K

Top Sellers

HolderShares% AssetsChange
Sixth street partners management company---184.29K
State of wisconsin investment board---24.80K
Vanguard portfolio management107.17K--16.79K
Brevan howard capital management lp---13.81K
Advantage alpha capital partners lp---13.66K

New Positions

HolderShares% AssetsChangeValue
Octagon capital advisors lp954.42K0.57%954.42K$6.29M
Millennium management18.49K-18.49K$121.84K
Price t rowe associates inc /md/15.03K-15.03K$100.00K
Federated hermes1.65K-1.65K$12.08K
Strategic financial concepts461.000.00%461.00$3.38K

Sold Out

HolderChange
Essential partners-1.00
Rothschild investment-1.00
Mai capital management-4.00
True wealth design-6.00
Massmutual trust co fsb/adv-12.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20266110.91%8,851,089159.77%969.62%4540.63%8-27.27%
Mar 31, 20265425.58%3,407,2791.87%326.54%3124.00%1137.50%
Dec 31, 202510-78.26%1,417,139-54.22%113.18%3-87.50%3-78.57%
Sep 30, 202515-65.12%1,514,519-54.84%112.00%6-80.65%5-28.57%
Jun 30, 2025464.55%3,409,78030.67%341.97%3447.83%7-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest1.04M0.98%428.05K
Vanguard Morn Total Stk Mkt Idx Investor614.65K0.55%-103.70K
Vanguard Total Stock Mkt Idx Inv614.65K0.55%-103.70K
iShares Russell 2000 ETF385.67K0.36%-
Vanguard Institutional Extnd Mkt Idx Tr238.69K0.23%-
Fidelity Small Cap Index199.91K0.19%-
Schwab US Small-Cap ETF™185.22K0.17%416.00
Fidelity Extended Market Index166.31K0.16%56.04K
iShares Russell 2000 Growth ETF100.85K0.09%-381.00
Fidelity Total Market Index95.57K0.09%58.09K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 10, 2026Ye Weiguo Chief Operating OfficerSell$31.20K
Jun 09, 2026Ye Weiguo Chief Operating OfficerSell$18.45K
Jun 18, 2026Ye Weiguo Chief Operating OfficerSell$19.05K
Jun 11, 2026Ye Weiguo Chief Operating OfficerSell$17.28K
Jun 09, 2026Ye Weiguo Chief Operating OfficerSell$89.03K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q2-17
2026 Q1--
2025 Q3--
2025 Q2-12

GYRE Ownership FAQ


Who Owns Gyre Therapeutics?

Gyre Therapeutics shareholders are primarily institutional investors at 9.69%, followed by 74.40% insiders and 15.91% retail investors. The average institutional ownership in Gyre Therapeutics's industry, Biotech Stocks , is 385.89%, which Gyre Therapeutics falls below.

Who owns the most shares of Gyre Therapeutics?

Gyre Therapeutics’s largest shareholders are Sc china (3.75M shares, 3.73%), Vanguard capital management (1.47M shares, 1.46%), and Vanguard group (1.2M shares, 1.35%). Together, they hold 6.53% of Gyre Therapeutics’s total shares outstanding.

Does Blackrock own Gyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gyre Therapeutics.

Who is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Sc china is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.17% of its assets in 3.75M Gyre Therapeutics shares, valued at 27.49M$.

Who is the top mutual fund holder of Gyre Therapeutics shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Gyre Therapeutics shares, with 0.98% of its total shares outstanding invested in 1.04M Gyre Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools